Document is current

Any future updates will be listed below

Proteolysis Targeting Chimera (PROTACs): An Attractive Technology in CVD Therapeutics—Opportunities and Challenges

Crossref DOI link: https://doi.org/10.1007/978-981-97-5077-1_16

Published Online: 2024-09-01

Published Print: 2024

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark